Resistance to chloroquine and sulfadoxine-pyrimethamine in Plasmodium falciparum in Muheza district, Tanzania.
Warsame
M
M
Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.
Kilimali
V A
VA
Wernsdorfer
W H
WH
Lebbad
M
M
Rutta
A S
AS
Ericsson
O
O
D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002738:Chloroquine / Q000627:therapeutic use*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007223:Infant; D016778:Malaria, Falciparum / Q000097:blood / Q000188:drug therapy*; D008297:Male; D010963:Plasmodium falciparum / Q000187:drug effects*; D011739:Pyrimethamine / Q000008:administration & dosage*; D012008:Recurrence; D013413:Sulfadoxine / Q000008:administration & dosage*; D013636:Tanzania
D000962:Antimalarials; D006454:Hemoglobins; D013413:Sulfadoxine; D002738:Chloroquine; D011739:Pyrimethamine